Alicia J. Hager's Net Worth
$620 Thousand
Who is Alicia J. Hager?
Alicia J. Hager does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nkarta, Inc., and OncoMed Pharmaceuticals Inc.
SEC CIK
Alicia J. Hager's CIK is 0001553354
Past Insider Trading and Trends
2022 was Alicia J. Hager's most active year for acquiring shares with 5 total transactions. Alicia J. Hager's most active month to acquire stocks was the month of December. 2024 was Alicia J. Hager's most active year for disposing of shares, totalling 3 transactions. Alicia J. Hager's most active month to dispose stocks was the month of December. 2020 saw Alicia J. Hager paying a total of $0.00 for 150,000 shares, this is the most they've acquired in one year. In 2024 Alicia J. Hager cashed out on 8,677 shares for a total of $71,041.16, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nkarta, Inc. (NKTX) Snapshot price: $5.2
Chief Legal OfficerAlicia J. Hager owns 103,819 units of Common Stock which is worth $539,858.80. From 2020 to 2024 Alicia J. Hager acquired a total of 114,300 shares in Nkarta, Inc., Alicia also disposed a total of 10,481 shares of Nkarta, Inc. equalling to $80,496.48.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.17% | -3.40K |
$8.00 | -$27,168.00 | 103.82K |
Jul 16
| |||
Form 4
| -0.67% | -727.00 |
$5.60 | -$4,071.20 | 107.22K |
Jun 18
| |||
Form 4
| -4.05% | -4.55K |
$8.74 | -$39,801.96 | 107.94K |
Jan 16
| |||
Form 4
| +99.12% | 56K |
—
|
—
| 112.5K |
Jan 4
| |||
Form 4
| -1.23% | -701.00 |
$4.85 | -$3,399.85 | 56.5K |
Jun 20
| |||
Form 4
| +174.99% | 36.4K |
$5.49 | -$6,055.47 | 57.2K |
Jan 13 - Jan 17
| |||
Form 4
| +62.50% | 8K |
—
|
—
| 20.8K |
Jun 17
| |||
Form 4
|
∞
| 12.8K |
—
|
—
| 12.8K |
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OncoMed Pharmaceuticals Inc No price found
VP & General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||